JP2009501533A - 顆粒膜細胞アポトーシスの調節 - Google Patents

顆粒膜細胞アポトーシスの調節 Download PDF

Info

Publication number
JP2009501533A
JP2009501533A JP2008521742A JP2008521742A JP2009501533A JP 2009501533 A JP2009501533 A JP 2009501533A JP 2008521742 A JP2008521742 A JP 2008521742A JP 2008521742 A JP2008521742 A JP 2008521742A JP 2009501533 A JP2009501533 A JP 2009501533A
Authority
JP
Japan
Prior art keywords
bmp
oocyte
activity
modulating
signaling pathway
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008521742A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009501533A5 (https=
Inventor
ギルクライスト，ロバート，ブルース
トンプソン，ジェレミー
フセイン，タミー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovation and Commercial Partners Pty Ltd
Original Assignee
Adelaide Research and Innovation Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2005903782A external-priority patent/AU2005903782A0/en
Application filed by Adelaide Research and Innovation Pty Ltd filed Critical Adelaide Research and Innovation Pty Ltd
Publication of JP2009501533A publication Critical patent/JP2009501533A/ja
Publication of JP2009501533A5 publication Critical patent/JP2009501533A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0608—Germ cells
    • C12N5/0609—Oocytes, oogonia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1841—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/155—Bone morphogenic proteins [BMP]; Osteogenins; Osteogenic factor; Bone inducing factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/19—Growth and differentiation factors [GDF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/04—Coculture with; Conditioned medium produced by germ cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2008521742A 2005-07-18 2006-07-18 顆粒膜細胞アポトーシスの調節 Pending JP2009501533A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2005903782A AU2005903782A0 (en) 2005-07-18 Modulation of granulosa cell apoptosis
PCT/AU2006/001002 WO2007009166A1 (en) 2005-07-18 2006-07-18 Modulation of granulosa cell apoptosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013141544A Division JP5841973B2 (ja) 2005-07-18 2013-07-05 顆粒膜細胞アポトーシスの調節

Publications (2)

Publication Number Publication Date
JP2009501533A true JP2009501533A (ja) 2009-01-22
JP2009501533A5 JP2009501533A5 (https=) 2009-09-03

Family

ID=37668339

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008521742A Pending JP2009501533A (ja) 2005-07-18 2006-07-18 顆粒膜細胞アポトーシスの調節
JP2013141544A Expired - Fee Related JP5841973B2 (ja) 2005-07-18 2013-07-05 顆粒膜細胞アポトーシスの調節

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013141544A Expired - Fee Related JP5841973B2 (ja) 2005-07-18 2013-07-05 顆粒膜細胞アポトーシスの調節

Country Status (8)

Country Link
US (2) US8530235B2 (https=)
EP (2) EP2228070B1 (https=)
JP (2) JP2009501533A (https=)
KR (1) KR101502110B1 (https=)
CN (1) CN101272804A (https=)
CA (1) CA2615006A1 (https=)
DK (1) DK2228070T3 (https=)
WO (1) WO2007009166A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014018404A1 (en) * 2012-07-21 2014-01-30 Baylor College Of Medicine Gdf9:bmp15 heterodimers for enhancing fertility
US20160237402A1 (en) * 2013-10-07 2016-08-18 Northeastern University Methods and Compositions for Ex Vivo Generation of Developmentally Competent Eggs from Germ Line Cells Using Autologous Cell Systems
EP3122366A4 (en) 2014-03-27 2017-11-15 Jonathan Lee Tilly Methods for growth and maturation of ovarian follicles
EP3577457A4 (en) * 2017-02-01 2021-01-20 Robert Bruce Gilchrist GROWTH FACTORS SECRETED BY GAMETES
CN112601756A (zh) 2018-05-09 2021-04-02 莫拿什大学 用于增强生育力的剂和方法
CN116814685B (zh) * 2023-06-05 2025-05-06 华南农业大学 Zfp42基因在猪卵巢颗粒细胞中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0678101A4 (en) 1993-01-12 1997-07-16 Univ Johns Hopkins Med FACTOR-9 OF GROWTH AND DIFFERENTIATION.
US6030617A (en) * 1993-01-12 2000-02-29 The Johns Hopkins University School Of Medicine Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
AU753793B2 (en) * 1998-04-01 2002-10-31 Baylor College Of Medicine Assay for growth differentiation factor 9
DE69907725T2 (de) * 1998-12-01 2004-03-18 Akzo Nobel N.V. Verbesserung der follikelgenese
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
FR2812004B1 (fr) * 2000-07-24 2002-12-27 Ccd Lab Milieux de culture pour fecondation in vitro, ou pour la culture de follicules, cellules germinales males ou embryons
WO2005097978A1 (en) * 2004-04-06 2005-10-20 Adelaide Research & Innovation Pty Ltd Modulation of granulosa cell proliferation and differentiation
JP2008521891A (ja) * 2004-12-02 2008-06-26 アグリサーチ・リミテッド 排卵の調節

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
JPN6012001042; ＬＩ，Ｒ．　ｅｔ　ａｌ．: 'Ｏｏｃｙｔｅ-ｓｅｃｒｅｔｅｄ　ｆａｃｔｏｒ（ｓ）　ｄｅｔｅｒｍｉｎｅ　ｆｕｎｃｔｉｏｎａｌ　ｄｉｆｆｅｒｅｎｃｅｓ　ｂｅｔｗｅｅｎ　ｂｏｖｉｎｅ　ｍｕｒａｌ　ｇｒａｎｕｌｏｓａ　ｃｅｌｌｓ　ａｎｄ' Ｂｉｏｌ．　Ｒｅｐｒｏｄ． Ｖｏｌ．６３，　Ｎｏ．３, 200009, ｐｐ．８３９-４５ *
JPN6012001043; ＧＩＬＣＨＲＩＳＴ，Ｒ．Ｂ．　ｅｔ　ａｌ．: 'Ｏｏｃｙｔｅ-ｓｏｍａｔｉｃ　ｃｅｌｌ　ｉｎｔｅｒａｃｔｉｏｎｓ　ｄｕｒｉｎｇ　ｆｏｌｌｉｃｌｅ　ｄｅｖｅｌｏｐｍｅｎｔ　ｉｎ　ｍａｍｍａｌｓ．' Ａｎｉｍ．　Ｒｅｐｒｏｄ．　Ｓｃｉ． Ｖｏｌ．８２-８３, 200407, ｐｐ．４３１-４６ *
JPN6012044830; ＭｃＮＡＴＴＹ，Ｋ．Ｐ．　ｅｔ　ａｌ．: 'Ｂｏｎｅ　ｍｏｒｐｈｏｇｅｎｅｔｉｃ　ｐｒｏｔｅｉｎ　１５　ａｎｄ　ｇｒｏｗｔｈ　ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ　ｆａｃｔｏｒ　９　ｃｏ-ｏｐｅｒａｔｅ　ｔｏ　ｒｅｇｕｌａｔｅ　ｇｒａｎｕｌｏｓａ　ｃ' Ｒｅｐｒｏｄｕｃｔｉｏｎ Ｖｏｌ．１２９，　Ｎｏ．４, 200504, ｐｐ．４７３-８０ *
JPN6012044834; ＭｃＮＡＴＴＹ，Ｋ．Ｐ．　ｅｔ　ａｌ．: 'Ｂｏｎｅ　ｍｏｒｐｈｏｇｅｎｅｔｉｃ　ｐｒｏｔｅｉｎ　１５　ａｎｄ　ｇｒｏｗｔｈ　ｄｉｆｆｅｒｅｎｔｉａｔｉｏｎ　ｆａｃｔｏｒ　９　ｃｏ-ｏｐｅｒａｔｅ　ｔｏ　ｒｅｇｕｌａｔｅ　ｇｒａｎｕｌｏｓａ　ｃ' Ｒｅｐｒｏｄｕｃｔｉｏｎ Ｖｏｌ．１２９，　Ｎｏ．４, 200504, ｐｐ．４８１-７ *
JPN7012000082; ＶＡＮＤＥＲＨＹＤＥＮ，Ｂ．Ｃ．　ｅｔ　ａｌ．: 'Ｍｏｕｓｅ　ｏｏｃｙｔｅｓ　ｐｒｏｍｏｔｅ　ｐｒｏｌｉｆｅｒａｔｉｏｎ　ｏｆ　ｇｒａｎｕｌｏｓａ　ｃｅｌｌｓ　ｆｒｏｍ　ｐｒｅａｎｔｒａｌ　ａｎｄ　ａｎｔｒａｌ　ｆｏｌｌｉｃｌｅｓ　ｉｎ　ｖｉｔｒｏ．' Ｂｉｏｌ．　Ｒｅｐｒｏｄ． Ｖｏｌ．４６，　Ｎｏ．６, 199206, ｐｐ．１１９６-２０４ *

Also Published As

Publication number Publication date
DK2228070T3 (da) 2017-01-02
EP1909820A4 (en) 2009-08-12
WO2007009166A1 (en) 2007-01-25
CN101272804A (zh) 2008-09-24
US20140073052A1 (en) 2014-03-13
EP2228070A3 (en) 2010-12-29
EP2228070A2 (en) 2010-09-15
JP5841973B2 (ja) 2016-01-13
US20080274963A1 (en) 2008-11-06
EP2228070B1 (en) 2016-09-07
KR101502110B1 (ko) 2015-03-12
KR20080043783A (ko) 2008-05-19
EP1909820A1 (en) 2008-04-16
CA2615006A1 (en) 2007-01-25
JP2013215207A (ja) 2013-10-24
US8530235B2 (en) 2013-09-10

Similar Documents

Publication Publication Date Title
Hsueh et al. Intraovarian control of early folliculogenesis
US10792311B2 (en) Stimulation of ovarian follicle development and oocyte maturation
JP5841973B2 (ja) 顆粒膜細胞アポトーシスの調節
Kushnir et al. Potential therapeutic applications of human anti-Müllerian hormone (AMH) analogues in reproductive medicine
CN105025912B (zh) 卵泡发育和卵细胞成熟的刺激
Thomas et al. How to make a good oocyte: an update on in‐vitro models to study follicle regulation
US20170051249A1 (en) Manipulation of ovarian primordial follicles
Li et al. Follicular development and oocyte growth
Moniruzzaman et al. Growth of primordial oocytes in neonatal and adult mammals
Hammami et al. In vitro developmental competence of prepubertal goat oocytes cultured with recombinant activin-A
AU2006272440B2 (en) Modulation of granulosa cell apoptosis
Singh et al. Influence of the ovarian reserve and oocyte quality on livestock fertility
Naz et al. Novel testis/sperm-specific contraceptive targets identified using gene knockout studies
WO2005097978A1 (en) Modulation of granulosa cell proliferation and differentiation
Godin Pagé The role of Nodal in the modulation of the maternal immune system in early pregnancy
Oh et al. Effects of pregnancy serum and scriptaid on development in early partheno embryo
WO2014131891A1 (en) Use of fetuin-b for culture of oocytes
Pagé The role of Nodal in the modulation of the maternal immune system in early pregnancy
Dietzel et al. The biological role of fetuin-B: inhibition of zona pellucida hardening and preservation of female fertility in mice
Chansaenroj Follicular responsiveness to equine chorionic gonadotropin in cat species: study in in vitro culture
PRABHAVATHI INFLUENCE OF LEPTIN ON THE EXPRESSION OF p53 and BAK GENES IN CULTURED OVARIAN FOLLICLES IN SHEEP
Robertsa Quadrupling efficiency in production of genetically modified pigs through improved oocyte maturation
Lingenfelter The effect of follicular aging on gene expression in oocytes and granulosal cells
NZ627450B2 (en) Stimulation of ovarian follicle development and oocyte maturation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090717

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090717

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120417

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120424

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120517

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120524

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20120618

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120620

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20120625

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120828

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121126

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121203

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121228

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130110

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130125

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130305